LianBio ADR Correlations

LIANDelisted Stock  USD 2.18  0.05  2.24%   
The current 90-days correlation between LianBio ADR and NextCure is 0.08 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LianBio ADR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LianBio ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

LianBio ADR Correlation With Market

Good diversification

The correlation between LianBio ADR and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding LianBio ADR and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving together with LianBio Stock

  0.69MCD McDonalds Fiscal Year End 3rd of February 2025 PairCorr
  0.69DD Dupont De Nemours Fiscal Year End 4th of February 2025 PairCorr

Moving against LianBio Stock

  0.38BA Boeing Fiscal Year End 29th of January 2025 PairCorr
  0.31BKRKF PT Bank RakyatPairCorr
  0.31EC Ecopetrol SA ADRPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
HOOKINZY
INZYMACK
TERNMACK
TERNGRPH
TERNINZY
HOOKTERN
  
High negative correlations   
ELDNGRPH
ELDNINZY
ELDNMACK
ELDNTERN
HOOKELDN
ELDNNXTC

Risk-Adjusted Indicators

There is a big difference between LianBio Stock performing well and LianBio ADR Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze LianBio ADR's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SNSE  6.98  0.59  0.04 (0.65) 7.80 
 10.20 
 110.76 
NXTC  2.58 (0.37) 0.00  1.76  0.00 
 5.22 
 21.68 
NUVB  3.61 (0.44)(0.02) 0.00  4.52 
 9.48 
 21.30 
GRPH  2.36 (0.13) 0.00 (0.39) 0.00 
 4.79 
 14.40 
MACK  0.78 (0.08) 0.00 (0.29) 0.00 
 1.89 
 7.02 
INZY  2.76 (1.20) 0.00 (0.59) 0.00 
 5.07 
 16.62 
DAWN  2.05 (0.11) 0.00 (0.02) 0.00 
 3.84 
 11.44 
TERN  3.39 (0.35) 0.00 (0.23) 0.00 
 6.02 
 34.09 
ELDN  3.47  0.70  0.17  16.47  3.04 
 10.09 
 28.12 
HOOK  2.87 (1.29) 0.00 (1.14) 0.00 
 6.85 
 22.98 

View LianBio ADR Related Equities

 Risk & Return  Correlation

LianBio ADR Corporate Management

Jiang QianChina MangProfile
Konstantin PoukalovFounder ChairmanProfile
Ji ChenSenior CounselProfile
Debra MDPres OfficerProfile
Levvy EngSenior DevelopmentProfile

Still Interested in LianBio ADR?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.